Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Non-invasive brain stimulation in neurological diseases

Schulz R, Gerloff C, Hummel FC.

Neuropharmacology. 2013 Jan;64:579-87. doi: 10.1016/j.neuropharm.2012.05.016. Epub 2012 Jun 9.

Autoimmunity, dendritic cells and relevance for Parkinson's disease

Koutsilieri E, Lutz MB, Scheller C.

J Neural Transm (Vienna). 2013 Jan;120(1):75-81. doi: 10.1007/s00702-012-0842-7. Epub 2012 Jun 15.

Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion

Luigetti M, Quaranta D, Conte A, Piccininni C, Lattante S, Romano A, Silvestri G, Zollino M, Sabatelli M.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Jan;14(1):66-9. doi: 10.3109/17482968.2012.692383. Epub 2012 Jun 18.

Dopamine reverses reward insensitivity in apathy following globus pallidus lesions

Adam R, Leff A, Sinha N, Turner C, Bays P, Draganski B, Husain M.

Cortex. 2013 May;49(5):1292-303. doi: 10.1016/j.cortex.2012.04.013. Epub 2012 May 17.

Deep brain stimulation for the treatment of Alzheimer disease and dementias

Laxton AW, Lozano AM.

World Neurosurg. 2013 Sep-Oct;80(3-4):S28.e1-8. doi: 10.1016/j.wneu.2012.06.028. Epub 2012 Jun 19.

Hyperacute T-waves: Wolff-Parkinson-White pattern or acute coronary syndrome?

Ragbir S, Jneid H, Hassan S, Bozkurt B.

J Emerg Med. 2013 Feb;44(2):332-5. doi: 10.1016/j.jemermed.2011.10.031. Epub 2012 Jun 21.

Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria

Eckert GP, Lipka U, Muller WE.

Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):105-14. doi: 10.1016/j.plefa.2012.05.006. Epub 2012 Jun 22.

Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Kansara S, Trivedi A, Chen S, Jankovic J, Le W.

J Neural Transm (Vienna). 2013 Jan;120(1):197-210. doi: 10.1007/s00702-012-0840-9. Epub 2012 Jun 26.

Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis

Mariani S, Ventriglia M, Simonelli I, Donno S, Bucossi S, Vernieri F, Melgari JM, Pasqualetti P, Rossini PM, Squitti R.

Neurobiol Aging. 2013 Feb;34(2):632-3. doi: 10.1016/j.neurobiolaging.2012.05.015. Epub 2012 Jun 26.

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes

Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP.

Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Epub 2012 Jun 28.

Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease

Pouclet H, Derkinderen P, Lebouvier T.

Clin Neurol Neurosurg. 2013 Feb;115(2):235-6. doi: 10.1016/j.clineuro.2012.05.016. Epub 2012 Jun 27.

A controlled clinical trial investigating the effects of cycle ergometry training on exercise tolerance, balance and quality of life in patients with Parkinson's disease

Lauhoff P, Murphy N, Doherty C, Horgan NF.

Disabil Rehabil. 2013 Mar;35(5):382-7. doi: 10.3109/09638288.2012.694962. Epub 2012 Jul 2.

Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation

Stenberg JH, Terevnikov V, Joffe M, Tiihonen J, Chukhin E, Burkin M, Joffe G.

Neuropharmacology. 2013 Jan;64:248-53. doi: 10.1016/j.neuropharm.2012.06.028. Epub 2012 Jun 26.

Animal models of Parkinson's disease: limits and relevance to neuroprotection studies

Bezard E, Yue Z, Kirik D, Spillantini MG.

Mov Disord. 2013 Jan;28(1):61-70. doi: 10.1002/mds.25108. Epub 2012 Jul 2.

Stimulation region within the globus pallidus does not affect verbal fluency performance

Dietz J, Noecker AM, McIntyre CC, Mikos A, Bowers D, Foote KD, Okun MS.

Brain Stimul. 2013 May;6(3):248-53. doi: 10.1016/j.brs.2012.05.011. Epub 2012 Jun 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias